 Company Announces Successful Completion of Tender Offer Moves Forward with Strategic Funding Partnership with Royalty Pharma PLANEGG MUNICH, GERMANY ACCESSWIRE July 15, 2021 MorphoSys AG FSE:MOR; NASDAQ:MOR MorphoSys today announced the successful completion of its previously announced cash tender offer for all outstanding shares of Constellation Pharmaceuticals, Inc. NASDAQ:CNST Constellation for 34.00 per share, net to the seller in cash, without interest and subject to any applicable withholding of taxes. The tender offer expired at one minute after 11:59 p.m. 